labetalol has been researched along with Uterine Neoplasms in 1 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Uterine Neoplasms: Tumors or cancer of the UTERUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Differentiation from acute cerebral ischemia is important in order to prevent permanent vision loss due to delay in initiating prompt and vigorous treatment of exacerbating factors, such as intermittent hypertension." | 1.36 | Postoperative blindness associated with posterior reversible encephalopathy syndrome: a case report. ( Kim, TK; Kim, WS; Lee, HJ; Park, SC; Yoon, JU; Yoon, JY, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, TK | 1 |
| Yoon, JU | 1 |
| Park, SC | 1 |
| Lee, HJ | 1 |
| Kim, WS | 1 |
| Yoon, JY | 1 |
1 other study available for labetalol and Uterine Neoplasms
| Article | Year |
|---|---|
Postoperative blindness associated with posterior reversible encephalopathy syndrome: a case report.
Topics: Adrenergic beta-Antagonists; Adult; Blindness; Brain Diseases; Brain Ischemia; Diagnosis, Differenti | 2010 |